NPI: 1578593927 · EATONTOWN, NJ 07724 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,556 | $933K |
| 2019 | 9,781 | $886K |
| 2020 | 10,174 | $737K |
| 2021 | 11,653 | $281K |
| 2022 | 15,936 | $228K |
| 2023 | 4,903 | $72K |
| 2024 | 1,872 | $84K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,674 | 1,730 | $1.58M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,203 | 959 | $931K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,590 | 885 | $487K |
| A4657 | Syringe, with or without needle, each | 3,975 | 1,389 | $63K |
| J1756 | Injection, iron sucrose, 1 mg | 2,267 | 488 | $34K |
| 85048 | 942 | 722 | $30K | |
| 85041 | 947 | 726 | $30K | |
| 83970 | 613 | 415 | $24K | |
| 83550 | 367 | 262 | $14K | |
| 83540 | 375 | 264 | $14K | |
| 82728 | 358 | 263 | $13K | |
| 82108 | 50 | 46 | $940.24 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 37 | 12 | $48.58 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 372 | 160 | $3.06 |
| G0008 | Administration of influenza virus vaccine | 39 | 27 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 47 | 31 | $0.00 |
| 90674 | 19 | 13 | $0.00 |